Chapter 18: Fibrinogen, Thrombin, and the Fibrinolytic System

Ciesla, Betty
January 2007
Hematology in Practice;2007, p269
Book Chapter
Chapter 18 of the book "Hematology in Practice" is presented. It explores fibronogen, thrombin and the fibrinolytic system. It discusses the role of fibrinogen in hemostasis, fibrin formation, composition of fibrinogen, and fibrinogen disorders such as afibrinogenemia, hypofibrinogenemia, and dysfibrinogenemia. It explains the role of thrombin in the coagulation mechanism, along with the symptoms and laboratory results in acute disseminated intravascular coagulation.


Related Articles

  • Retrospective Evaluation of New Chinese Diagnostic Scoring System for Disseminated Intravascular Coagulation. Wang, Manzhi; Kou, Haiming; Deng, Jun; Wang, Huafang; Guo, Tao; Mei, Heng; Hu, Yu // PLoS ONE;Jun2015, Vol. 10 Issue 6, p1 

    Objectives: To retrospectively validate the new Chinese DIC scoring system (CDSS). Methods: This study retrospectively collected the information of 619 patients (371 cases with non-hematologic malignancies, 248 cases with hematologic malignancies) who suspected of DIC in Wuhan Union Hospital...

  • Microvascular Alterations in Thrombin-Induced Experimental Disseminated Intravascular Coagulation in the Dog. Vignolo-Scalone, Washington H.; Vignolo-Puglia, Washington H.; Kitchens, Craig S. // Angiology;May1984, Vol. 35 Issue 5, p261 

    Disseminated intravascular coagulation is often characterized by organ failure and bleeding. By use of light microscopy, previous studies have shown extensive fibrin deposition in vessels. However, quantification of fibrin deposition using ultrastructural methods has not been reported. In this...

  • Clinical: Haematology - Disseminated intravascular coagulation. Toh, Cheng-Hock; Thachil, Jecko // GP: General Practitioner;5/20/2011, p44 

    The article offers information on disseminated intravascular coagulation (DIC). DIC occurs when the human body loses its capacity to coagulate on being injured. Coagulation is an important part of hemostasis, that controls blood loss by forming clots on the wounds and injuries. DIC is caused by...

  • Good or Poor Responses of Hemostatic Molecular Markers in Patients with Hematopoietic Disorders After Treatment of Disseminated Intravascular Coagulation. Watanabe, Rika; Wada, Hideo; Yamamuro, Miho; Inoue, Akiko; Watanabe, Masato; Kumeda, Kousuke; Sakakura, Miho; Okugawa, Yoshinaga; Nakasaki, Takahiro; Deguchi, Hiroshi; Gabazza, Esteban C.; Mori, Yoshitaka; Nishikawa, Masakatsu; Nobori, Tutomu; Shiku, Hiroshi // Clinical & Applied Thrombosis/Hemostasis;Jan2003, Vol. 9 Issue 1, p71 

    Changes of hemostatic markers in 226 patients with disseminated intravascular coagulation (DIC) and hematopoietic disorders were examined after treatment of DIC. The changes in prothrombin time (PT) ratio, fibrinogen, fibrin and fibrinogen degradation products (FDP), antithrombin, and protein C,...

  • Laboratory Diagnostics in Septic Disseminated Intravascular Coagulation. Lippi, Giuseppe; Guidi, Gian Cesare // European Critical Care & Emergency Medicine;2010, Vol. 2, p6 

    The diagnosis of septic disseminated intravascular coagulation (DIC) relies on clinical signs and symptoms, identification of the underlying disease and results of laboratory testing. Since no single test result alone can definitely establish or rule out the diagnosis, the laboratory diagnostics...

  • Diagnosing Disseminated Intravascular Coagulopathy in Acute Promyelocytic Leukemia. McCraw, Beth // Clinical Journal of Oncology Nursing;Oct2008, Vol. 12 Issue 5, p717 

    The article focuses on diagnosing disseminated intravascular coagulopathy (DIC) in acute promyelocytic leukemia. DIC is a complex life-threatening condition that causes a hypercoagulative state that results in inappropriate activation of the coagulation cascade which is triggered by the release...

  • Disseminated intravascular coagulation in a dog naturally infected by Leishmania (Leishmania) chagasi from Rio de Janeiro - Brazil. Honse, Carla O.; Figueiredo, Fabiano B.; de Alencar, Nayro X.; Madeira, Maria de Fátima; Gremião, Isabella D. F.; Schubach, Tânia M. P. // BMC Veterinary Research;2013, Vol. 9 Issue 1, p1 

    Background: Disseminated intravascular coagulation (DIC) is an acquired disorder characterized by the activation of intravascular coagulation and excessive fibrin formation. It always occurs in association with other clinical conditions, including parasitic diseases. DIC has been described as a...

  • Elevated Plasma Levels of Fibrin Degradation Products by Granulocyte-Derived Elastase in Patients with Disseminated Intravascular Coagulation. Matsumoto, Takeshi; Wada, Hideo; Nobori, Tsutomu; Nakatani, Kaname; Onishi, Katsuya; Nishikawa, Masakatsu; Shiku, Hiroshi; Kazahaya, Yumiko; Sawai, Tokio; Koike, Kaoru; Matsuda, Michio // Clinical & Applied Thrombosis/Hemostasis;Oct2005, Vol. 11 Issue 4, p391 

    Plasma levels of granulocyte-derived elastase (GE-XDP), D-dimer, and soluble fibrin (SF) were examined in 177 patients with disseminated intravascular coagulation (DIC) of various etiologies. Plasma levels of GE-XDP and D-dimer, but not SF, were significantly high in patients with sepsis and...

  • Plasma antigen levels of thrombin-activatable fibrinolysis inhibitor did not differ in patients with or without disseminated intravascular coagulation. Chih-Cheng Chen; Kuan-Der Lee; Jyh-Pyng Gau; Yuan-Bin Yu; Jie-Yu You; Su-Chung Lee; Hui-Chi Hsu; Wing-Keung Chau; Chao-Hung Ho // Annals of Hematology;Oct2005, Vol. 84 Issue 10, p675 

    Thrombin-activatable fibrinolysis inhibitor (TAFI) is a carboxypeptidase that downregulates fibrinolysis and might play some roles in the pathogenesis of disseminated intravascular coagulation (DIC). We prospectively examined the plasma TAFI antigen levels in patients highly suspected to be...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics